Day 7 (2020) Treatments
The Association of Migraine Disorders (AMD) is devoted to expanding the understanding of migraine disease and its true scope. Migraine is a full body condition with a broad spectrum of symptoms, AMD is focused on including many medical specialties in the management of this disease.
Theranica develops advanced yet affordable electroceuticals, addressing a few prevalent neurological pain diseases. The company’s first FDA-authorized product, Nerivio™, is available in the US. Nerivio is an innovative, non-invasive, smartphone-operated, prescribed wearable for the acute treatment of migraine. 12% of the world’s population suffer from migraine, of which 80% are women. Being completely drug-free, Nerivio™ is a safe, addiction-free alternative in the multi-billion-dollar market of medications for migraine.
Summaries now available for every interview with expert quotes, treatments mentioned, action items. Start making positive changes today with these guides. Only available with 2020 VIP Access Pass.
Today's Interviews
The Latest New Treatment Innovations
Peter Goadsby, MD, PhD, FRS
Professor of Neurology and Neurologist
King's College London
Are Migraine Surgeries Worth It?
William B. Young, MD
Neurologist and Headache Specialist
Jefferson Headache Center
Real-World Use of CGRP Medications
Brian Grosberg, MD
Director and Headache Specialist
Hartford HealthCare Headache Center
Multi-Disciplined Approach to Migraine Management
Tine Poole, MD
Director
The Migraine Clinic, Norway
Summit Menu
For a limited time get up to 27% OFF all the 2025 interviews, videos, audio, transcripts, and more. Why upgrade?
- Can’t attend live? Watch anytime
- Prefer reading or listening? Get transcripts and audio
- Want to dive deeper? Explore the additional footage & resources
- Need ongoing support? Reference expert advice year-round
- Lifetime access to 2025, no annual fee
- Act now, early-bird offer ends March 19th!
